(4-NH2)-Exatecan |
| Katalog-Nr.GC65358 |
(4-NH2)-Exatecan, ein Topoisomerase-Inhibitor-Derivat, extrahiert aus Patent US20200306243A1, Verbindung A. (4-NH2)-Exatecan kann bei der Synthese von AntikÖrper-Wirkstoff-Konjugaten (ADCs) verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2495742-21-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(4-NH2)-Exatecan, a topoisomerase inhibitor derivative extracted from patent US20200306243A1, compound A. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs)[1].
[1]. Howard PW, et, al. Compounds and conjugates thereof. US20200306243A1.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *